China Shineway Pharmaceutical Group Limited logo

China Shineway Pharmaceutical Group Limited (CSWYF)

Market Closed
7 Aug, 20:00
OTC PINK OTC PINK
$
1. 00
0
0%
$
758.42M Market Cap
7.19 P/E Ratio
0.48% Div Yield
100 Volume
0 Eps
$ 1
Previous Close
Add Transaction
Day Range
1 1
Year Range
0.93 1
Want to track CSWYF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CSWYF closed Friday higher at $1, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, CSWYF stock gained 8.5053%.
CSWYF pays dividends to its shareholders, with the most recent payment made on May 20, 2025. The next estimated payment will be in 20 May 2025 on May 20, 2025 for a total of $0.0497.
The last earnings report, released on Mar 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

CSWYF Chart

People also search for

Salvatore Ferragamo S.p.A.
$ 5.6
0%
Zeon Corporation - Unsponsored ADR
$ 9.73
0%
Shangri-La Asia Limited Sponsored ADR
$ 10.4
0%
Telecom Italia S.p.A. Sponsored ADR
$ 8.6
-2.0501%
Pandora A/S Sponsored ADR
$ 15.4
-1.7795%

China Shineway Pharmaceutical Group Limited (CSWYF) FAQ

What is the stock price today?

The current price is $1.00.

On which exchange is it traded?

China Shineway Pharmaceutical Group Limited is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is CSWYF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.48%.

What is its market cap?

As of today, the market cap is 758.42M.

Has China Shineway Pharmaceutical Group Limited ever had a stock split?

No, there has never been a stock split.

China Shineway Pharmaceutical Group Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
Zhenjiang Li CEO
OTC PINK Exchange
KYG2110P1000 ISIN
CN Country
3,220 Employees
4 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

China Shineway Pharmaceutical Group Limited operates as an investment holding entity primarily focused on the research, development, manufacturing, and trading of Chinese medicines. Established in 2002 and headquartered in Shijiazhuang, within the People’s Republic of China, it has cemented its presence in both the local Chinese market and Hong Kong. The company’s commitment to enhancing traditional Chinese medicine (TCM) is reflected through its wide range of product offerings and its expansion into various therapeutic domains. As a subsidiary of Forway Investment Limited, China Shineway Pharmaceutical continues to explore innovative solutions within the TCM industry, alongside its engagement in the trading of agricultural products, marking its diversified interests and business model adaptation to the evolving market needs and opportunities.

Products and Services

  • Soft Capsules:

    China Shineway Pharmaceutical has developed a range of soft capsules aimed at treating various health conditions. These capsules are designed to provide patients with an easy-to-consume form of traditional Chinese medicine, focusing on improving user compliance and medication absorption.

  • Granules:

    As part of its product lineup, the company offers granules, another popular form of traditional Chinese medicine. These granules are tailored for specific health conditions, providing a precise dosage that ensures effectiveness while maintaining the integrity of traditional medicinal practices.

  • Injections:

    In addition to oral formulations, China Shineway Pharmaceutical produces injections derived from TCM ingredients. These injections target severe or acute conditions, offering a potent and direct therapeutic effect that is critical for certain types of diseases and patients.

  • TCM Formula Granules:

    The company has also specialized in TCM formula granules, which encompass a variety of therapeutic areas such as respiratory, digestive, cardiovascular, and cerebrovascular diseases, orthopedics, pediatrics, and nervous system disorders. These formula granules are designed for the specific needs of different patient groups, focusing on both curing and preventing diseases with roots in TCM philosophy.

  • Medication for Strengthening the Body:

    Beyond treating specific ailments, China Shineway Pharmaceutical offers medications aimed at strengthening the body's immune system and overall health. These products are grounded in the preventive aspect of traditional Chinese medicine, emphasizing wellness and the promotion of long-term health.

  • Agricultural Products Trading:

    Expanding its business horizon, the company engages in the trading of agricultural products. This diversification reflects its strategic adaptation to market trends and its endeavor to leverage the extensive network and expertise developed through its core operations in pharmaceuticals.

Contact Information

Address: No. 168 Shiluan Street
Phone: 86 31 1880 30066